We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.65%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.51B
AUM Growth
-$59.4M
(-3.8%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
50.09%
Holding
339
New
32
Increased
81
Reduced
57
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIH
China Index Holdings Limited American Depository Shares
CIH
|
+$10.8M |
| 2 |
AbbVie
ABBV
|
+$7.55M |
| 3 |
QTT
Qutoutiao Inc. American Depositary Shares
QTT
|
+$4.66M |
| 4 |
Agios Pharmaceuticals
AGIO
|
+$3.3M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$20.3M |
| 2 |
DigitalBridge
DBRG
|
+$14.9M |
| 3 |
Brookdale Senior Living
BKD
|
+$12.7M |
| 4 |
Vipshop
VIPS
|
+$8.37M |
| 5 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
+$6.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.82% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 3.38% |
| 4 | Technology | 2.61% |
| 5 | Communication Services | 2.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
McKesson
MCK
$99.5B
| $1.07M | 0.07% |
7,985
| – | – |
|
152
Curis
CRIS
$9.14M
| $1.06M | 0.07% |
1,455
+463
| +47% | +$325K |
|
153
Amphenol
APH
$184B
| $1.05M | 0.07% |
43,840
| – | – |
|
154
CytomX Therapeutics
CTMX
$708M
| $1.03M | 0.07% |
97,457
+45,012
| +86% | +$472K |
|
|
LITS
155
Lite Strategy Inc
LITS
$33.2M
| $995K | 0.07% |
19,826
| – | – |
|
156
UBS Group
UBS
$172B
| $990K | 0.07% |
87,485
-83,440
| -49% | -$1.02M |
|
157
Advanced Micro Devices
AMD
$807B
| $984K | 0.07% |
+32,000
| New | +$913K |
|
158
SLB Ltd
SLB
$76.5B
| $978K | 0.06% |
25,000
-3,200
| -11% | -$129K |
|
159
AT&T
T
$167B
| $973K | 0.06% |
39,058
| – | – |
|
160
Pfizer
PFE
$141B
| $964K | 0.06% |
23,399
+3,795
| +19% | +$151K |
|
161
Spero Therapeutics
SPRO
$68.3M
| $962K | 0.06% |
86,596
-16,766
| -16% | -$202K |
|
162
T-Mobile US
TMUS
$190B
| $953K | 0.06% |
13,000
| – | – |
|
163
Omnicell
OMCL
$1.89B
| $949K | 0.06% |
+11,000
| New | +$894K |
|
|
SCHW
164
Charles Schwab
SCHW
$181B
| $941K | 0.06% |
23,400
+4,400
| +23% | +$192K |
|
|
CHMA
165
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $923K | 0.06% |
+123,954
| New | +$813K |
|
166
Norfolk Southern
NSC
$77.1B
| $905K | 0.06% |
4,680
-410
| -8% | -$81.3K |
|
167
Nasdaq
NDAQ
$52.5B
| $904K | 0.06% |
+28,200
| New | +$864K |
|
168
Philip Morris
PM
$305B
| $896K | 0.06% |
11,500
| – | – |
|
169
Rhythm Pharmaceuticals
RYTM
$7.28B
| $883K | 0.06% |
40,720
+11,000
| +37% | +$278K |
|
|
PRTK
170
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $875K | 0.06% |
227,383
| – | – |
|
171
Oracle
ORCL
$345B
| $832K | 0.05% |
14,655
| – | – |
|
|
SPPI
172
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $830K | 0.05% |
95,246
| – | – |
|
173
Cartesian Therapeutics
RNAC
$229M
| $824K | 0.05% |
14,611
| – | – |
|
174
IBM
IBM
$204B
| $819K | 0.05% |
6,187
| – | – |
|
175
Citigroup
C
$223B
| $818K | 0.05% |
12,000
| – | – |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
MHC
BWM
Fosun International's Q2 2019 Portfolio in Review
As of Q2 2019, Fosun International held 339 positions worth $1.51B, down 3.8% from $1.57B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Fosun International deployed $92.2M of net new capital in Q2 2019, opening 32 new positions and adding to 81 existing holdings. Its largest new stake was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was DigitalBridge, an estimated $14.9M trimmed.
- Fosun International's largest Q2 2019 buy was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
- Fosun International added most to Array Biopharma Inc in Q2 2019, an estimated $3.22M increase.
- Fosun International's biggest Q2 2019 reduction was DigitalBridge, cutting an estimated $14.9M.
- Fosun International fully exited Baozun in Q2 2019, selling an estimated $20.3M.
- Fosun International's ten largest holdings make up 50% of its $1.51B portfolio in Q2 2019.
- Fosun International opened 32 new positions and closed 39 in Q2 2019.
- Fosun International's portfolio value fell 3.8% quarter-over-quarter to $1.51B.
Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.